FDA gives Sanofi-Aventis green light for Novolog biosimilarMerilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. Hugh Chancy, former NCPA president, presses for PBM reform in Congressional hearingAnticompetitive PBM tactics lead to higher costs, limited choices and pharmacy deserts, Chancy said. What do consumers really think about generics? A Tebra survey found that 84% of Americans believe generic medications are just as effective as their brand-name counterparts. Watch DSN: Rite Aid bridges generational gap in pharmacy services with expanded clinical care Summer Kerley, group vice president, pharmacy growth and clinical programs at Rite Aid, shares how the retailer's expanding education around its clinical offerings strengthens patient-pharmacist relationships and improve health outcomes. AAM releases 2025 advocacy priorities, legislative reform recommendations The recommendations are a call to action to safeguard affordable generic and biosimilar medicines. XiFin webinar focuses on how pharmacy can unlock insights to drive innovation, growth The webinar explored strategies to help pharmacies boost patient outcomes and profitability. Time and money impact pharmacy A growing roster of technologies are freeing pharmacists from manual tasks, allowing them to perform higher-profit clinical services. Sustainable practices Pharmacies play a vital role in building sustainable communities. Camber launches sirolimus oral solution Sirolimus oral solution is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in certain patients. Justice Department files nationwide lawsuit against Walgreens The lawsuit alleges Walgreens knowingly filled millions of prescriptions that lacked a legitimate medical purpose. First Previous 1 2 3 4 5 Next Last
